These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 36641433)

  • 21. Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients.
    Yang H; Huang SG; Dong M; Wang X; He J; Su H; Liu C; Zhu Y; Wei L; Liu Z
    Biomol Biomed; 2024 Oct; 24(6):1586-1594. PubMed ID: 38761408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
    Ferrandina G; Distefano MG; De Vincenzo R; Salutari V; Petrillo M; Scarciglia ML; Pietragalla A; Conte C; Scambia G
    Gynecol Oncol; 2013 Mar; 128(3):518-23. PubMed ID: 23237767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
    Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
    Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
    Umayahara K; Takekuma M; Hirashima Y; Noda SE; Ohno T; Miyagi E; Hirahara F; Hirata E; Kondo E; Tabata T; Nagai Y; Aoki Y; Wakatsuki M; Takeuchi M; Toita T; Takeshima N; Takizawa K
    Gynecol Oncol; 2016 Feb; 140(2):253-8. PubMed ID: 26701414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    Zhang GY; Zhang R; Bai P; Li SM; Zhang YY; Chen YR; Huang MN; Wu LY
    BMC Cancer; 2022 Dec; 22(1):1331. PubMed ID: 36539745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dense Paclitaxel- and Carboplatin-based Neoadjuvant Chemotherapy Followed by Surgery or Concurrent Chemo-radiotherapy in Cervical Cancer: a Preliminary Analysis.
    Gadducci A; Barsotti C; Laliscia C; Cosio S; Fanucchi A; Tana R; Fabrini MG
    Anticancer Res; 2017 Mar; 37(3):1249-1255. PubMed ID: 28314289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Salihi R; Leunen K; Moerman P; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2017 Jul; 27(6):1256-1260. PubMed ID: 28574931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study.
    Angioli R; Plotti F; Luvero D; Aloisi A; Guzzo F; Capriglione S; Terranova C; De Cicco Nardone C; Benedetti-Panici P
    Tumour Biol; 2014 Mar; 35(3):2741-6. PubMed ID: 24234333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis.
    Sala P; Bogliolo S; Barra F; Fazio A; Maramai M; Cassani C; Gardella B; Babilonti L; Giannelli F; Mammoliti S; Spinillo A; Ferrero S; Valenzano Menada M; Costantini S; Bruzzi P; Marchiolè P
    J Invest Surg; 2022 Feb; 35(2):308-314. PubMed ID: 33289585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locally advanced cervical cancer - neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: A phase II study.
    Benson R; Pathy S; Kumar L; Mathur S; Dadhwal V; Mohanti BK
    J Cancer Res Ther; 2019; 15(6):1359-1364. PubMed ID: 31898673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
    Zeng J; Sun P; Ping Q; Jiang S; Hu Y
    PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
    Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial.
    Tovanabutra C; Asakij T; Rongsriyam K; Tangjitgamol S; Tharavichitkul E; Sukhaboon J; Kridakara LCA; Paengchit K; Khunnarong J; Atjimakul T; Pariyawateekul P; Tanprasert P; Tungkasamit T; Lorvidhaya V
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2977-2985. PubMed ID: 34582670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
    Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
    World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research.
    Gadducci A; Cosio S
    Anticancer Res; 2020 Sep; 40(9):4819-4828. PubMed ID: 32878770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma.
    Tang J; Tang Y; Yang J; Huang S
    Gynecol Oncol; 2012 May; 125(2):297-302. PubMed ID: 22307061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].
    Wang YT; Li B; Li XG; Ma SK; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):588-594. PubMed ID: 31550774
    [No Abstract]   [Full Text] [Related]  

  • 39. Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Xu T; Hu C; Zhu G; He X; Wu Y; Ying H
    Med Oncol; 2012 Mar; 29(1):272-8. PubMed ID: 21279704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study.
    Benedetti Panici P; Palaia I; Marchetti C; Ruscito I; Fischetti M; Musella A; Di Donato V; Perniola G; Vertechy L; Muzii L
    Oncology; 2015; 89(2):103-10. PubMed ID: 25924602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.